Literature DB >> 3501876

Interleukin-1 beta and interleukin-1 alpha stimulate the N-acetyl-beta-glucosaminidase activity of human synovial cells.

B J Clarris1, J R Fraser, P Ash, T Leizer, J A Hamilton.   

Abstract

The properties of synovial cells are altered in vitro by monocyte-macrophage polypeptides (monokines), and these changes could explain some of the properties of the inflamed synovium in rheumatoid disease. Purified monokines have become available only recently for testing on the target synovial cells. We report here that purified human interleukin (IL)-1 beta and recombinant human IL-1 alpha stimulate the extracellular activity of the lysosomal hydrolase, N-acetyl-beta-glucosaminidase (NAG), of human synovial fibroblast-like cells. In contrast, another monokine, synovial activator, does not increase the NAG activity. Thus NAG is another cellular activity which can be modulated by interleukin-1.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501876     DOI: 10.1007/BF00270528

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

1.  Human synovial-cell culture use of a new method in a study of rheumatoid arthritis.

Authors:  J R FRASER; K J CATT
Journal:  Lancet       Date:  1961-12-30       Impact factor: 79.321

2.  Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc. Natl. Acad. Sci. USA 1984. 81: 7907-7911.

Authors:  Philip E Auron; Andrew C Webb; Lanny J Rosenwasser; Steven F Mucci; Alexander Rich; Sheldon M Wolff; Charles A Dinarello
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

3.  Relation of cellular infiltration of rheumatoid synovial membrane to its immune response.

Authors:  M Ziff
Journal:  Arthritis Rheum       Date:  1974 May-Jun

4.  Lysosomal enzymes in synovial membrane in rheumatoid arthritis. Relationship to joint damage.

Authors:  K D Muirden
Journal:  Ann Rheum Dis       Date:  1972-07       Impact factor: 19.103

5.  Acid phosphatase activity in rheumatoid synovia.

Authors:  O Wegelius; M Klockars; K Vainio
Journal:  Acta Med Scand       Date:  1968-06

6.  Relationship between chromosomal changes and alterations in the behaviour of a strain of human synovial cells during its life history in vitro.

Authors:  B J Clarris; J R Fraser
Journal:  Ann Rheum Dis       Date:  1968-11       Impact factor: 19.103

7.  Lysosomal activation by neutral saccharides in cell cultures of synovium.

Authors:  J L Marshall; J R Fraser; K D Muirden
Journal:  Ann Rheum Dis       Date:  1977-04       Impact factor: 19.103

8.  Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.

Authors:  A Fontana; H Hengartner; E Weber; K Fehr; P J Grob; G Cohen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

9.  Streptococcal cell walls and synovial cell activation. Stimulation of synovial fibroblast plasminogen activator activity by monocytes treated with group A streptococcal cell wall sonicates and muramyl dipeptide.

Authors:  J A Hamilton; J B Zabriskie; L B Lachman; Y S Chen
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

10.  Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts.

Authors:  J Chin; P M Cameron; E Rupp; J A Schmidt
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more
  2 in total

1.  Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes.

Authors:  T Tawara; M Shingu; M Nobunaga; T Naono
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  Monocyte activation in early onset rheumatoid arthritis.

Authors:  I Fujii; M Shingu; M Nobunaga
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.